Stepan Reports Record Third Quarter Results and Nine Month Earnings
Third Quarter Highlights
- Reported net income was
$33.2 million , or$1.43 per diluted share versus$25.9 million , or$1.11 per diluted share, in the prior year. Adjusted net income* was$36.4 million , or$1.56 per diluted share, up 30% versus$27.9 million , or$1.20 per diluted share, in the prior year.Total Company sales volume increased 5% versus the prior year. - Surfactant operating income was
$41.2 million versus$19.7 million in the prior year. This increase was primarily attributable to an 8% increase in global sales volume as well as an improved product and customer mix. The sales volume growth was principally due to higher demand for cleaning, disinfection and personal wash products as a result of COVID-19. Quarterly operating results also benefited from a$3.9 million operating improvement inMexico . As previously announced, the Company closed on its agreement to acquire Clariant's anionic surfactant business and associated sulfonation equipment inMexico . - Polymer operating income was
$22.4 million versus$23.3 million in the prior year. This decrease was mostly attributable to a 5% decline in global Polymer sales volume versus prior year. North American rigid polyol sales volume declined 8% while European volume was up slightly. The lower North American volume reflects construction project delays and cancellations due to COVID-19. Lower demand within the phthalic anhydride business also contributed to the sales volume decline. - The Company recognized
$5.0 million pre-tax of partial insurance recovery related to the first quarter 2020 Millsdale, IL plant power outage. Surfactant and Polymer operating income benefited$2.2 million and$2.8 million , respectively, in the quarter. The Company continues to work with its insurance provider on the remainder of the claim. - Specialty Product operating income was
$1.6 million versus$2.3 million in the prior year. This decrease was primarily attributable to lower margins within our medium chain triglycerides (MCT) product line and customer order patterns within our food and flavor business. - The effect of foreign currency translation negatively impacted net sales by 2% and net income by
$1.6 million , or$0.07 per diluted share, versus the prior year. - The Company had negative net debt at quarter-end as cash balances of
$310.4 million exceed total debt of$207.9 million . - The Company increased its quarterly cash dividend in the fourth quarter of 2020 by
$0 .03 per share, or 11%, marking the 53rd consecutive year that the Company has increased its cash dividend to stockholders.
YTD Highlights
- Reported net income was
$96.4 million , or$4.15 per diluted share, versus$81.1 million , or$3.48 per diluted share, in the prior year. Adjusted net income* was$98.9 million , or$4.25 per diluted share, versus$93.7 million , or$4.02 per diluted share, in the prior year.Total Company sales volume increased 2% compared to the first nine months of 2019. A 5% increase in global Surfactants sales volume was partially offset by a 9% decrease in global Polymer sales volume.
* Adjusted net income is a non-GAAP measure which excludes deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share.
"Today, the world continues to be challenged by the global pandemic. At Stepan, we are committed to do our part by supporting customers that supply essential cleaning, disinfection and personal wash products to the market. We are grateful to our employees for their passion and commitment to get the job done for our customers and for
"The Company delivered record third quarter and year-to-date results. Surfactant third quarter operating income was up significantly on volume growth, which was mostly attributable to strong demand in the consumer product end markets driven by the fight against the COVID-19 virus. Operations in
Financial Summary
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||||
($ in thousands, except per share data) |
2020 |
2019 |
% Change |
2020 |
2019 |
% Change |
|||||||||||||||||
|
$ |
464,480 |
$ |
451,582 |
3 |
% |
$ |
1,375,016 |
$ |
1,413,755 |
(3) |
% |
|||||||||||
Operating Income |
$ |
42,395 |
$ |
27,966 |
52 |
% |
$ |
127,022 |
$ |
98,769 |
29 |
% |
|||||||||||
Net Income Attributable to |
$ |
33,168 |
$ |
25,889 |
28 |
% |
$ |
96,420 |
$ |
81,091 |
19 |
% |
|||||||||||
Earnings per Diluted Share |
$ |
1.43 |
$ |
1.11 |
29 |
% |
$ |
4.15 |
$ |
3.48 |
19 |
% |
|||||||||||
Adjusted Net Income * |
$ |
36,421 |
$ |
27,929 |
30 |
% |
$ |
98,894 |
$ |
93,695 |
6 |
% |
|||||||||||
Adjusted Earnings per Diluted Share * |
$ |
1.56 |
$ |
1.20 |
30 |
% |
$ |
4.25 |
$ |
4.02 |
6 |
% |
* See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share. |
Summary of Third Quarter Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense and other significant and infrequent or non-recurring items.
- Deferred Compensation: The current year third quarter includes
$2.6 million of after-tax expense versus$1.4 million of after-tax expense in the prior year. - Cash-Settled SARs: These management incentive instruments provide cash to participants equal to the appreciation on the price of specified shares of Company stock over a specified period of time. Because income or expense is recognized merely on the movement in the price of Company stock it has been excluded, similar to deferred compensation, to arrive at adjusted net income. The current year third quarter includes
$0.5 million of after-tax expense versus$0.3 million of after-tax expense in the prior year. - Business Restructuring: The current year third quarter includes
$0.1 million of after-tax decommissioning expense related to the Company's Canadian plant closure versus$0.3 million of after-tax expense in 2019.
Percentage Change in
Net sales increased 3% in the year-over-year third quarter due to a 5% increase in global sales volume that was partially offset by the unfavorable impact of foreign currency translation. The higher sales volume primarily reflects Surfactant growth of 8% partially offset by a Polymer decline of 5%.
Three Months Ended |
Nine Months Ended |
|||||||
Volume |
5 |
% |
2 |
% |
||||
Selling Price & Mix |
– |
(2) |
% |
|||||
Foreign Translation |
(2) |
% |
(3) |
% |
||||
Total |
3 |
% |
(3) |
% |
Reported Segment Results
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2020 |
2019 |
% |
2020 |
2019 |
% |
||||||||||||||||||
|
||||||||||||||||||||||||
Surfactants |
$ |
333,839 |
$ |
299,719 |
11 |
% |
$ |
993,245 |
$ |
962,749 |
3 |
% |
||||||||||||
Polymers |
$ |
116,682 |
$ |
135,089 |
(14) |
% |
$ |
335,582 |
$ |
395,904 |
(15) |
% |
||||||||||||
Specialty Products |
$ |
13,959 |
$ |
16,774 |
(17) |
% |
$ |
46,189 |
$ |
55,102 |
(16) |
% |
||||||||||||
Total |
$ |
464,480 |
$ |
451,582 |
3 |
% |
$ |
1,375,016 |
$ |
1,413,755 |
(3) |
% |
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands, all amounts pre-tax) |
2020 |
2019 |
% Change |
2020 |
2019 |
% Change |
||||||||||||||||||
Operating Income |
||||||||||||||||||||||||
Surfactants |
$ |
41,151 |
$ |
19,660 |
109 |
% |
$ |
125,810 |
$ |
88,913 |
41 |
% |
||||||||||||
Polymers |
$ |
22,387 |
$ |
23,283 |
(4) |
% |
$ |
45,430 |
$ |
58,148 |
(22) |
% |
||||||||||||
Specialty Products |
$ |
1,593 |
$ |
2,261 |
(30) |
% |
$ |
8,803 |
$ |
11,374 |
(23) |
% |
||||||||||||
Total Segment Operating Income |
$ |
65,131 |
$ |
45,204 |
44 |
% |
$ |
180,043 |
$ |
158,435 |
14 |
% |
||||||||||||
Corporate Expenses |
$ |
(22,736) |
$ |
(17,238) |
(32) |
% |
$ |
(53,021) |
$ |
(59,666) |
11 |
% |
||||||||||||
Consolidated Operating Income |
$ |
42,395 |
$ |
27,966 |
52 |
% |
$ |
127,022 |
$ |
98,769 |
29 |
% |
Total segment operating income increased
- Surfactant net sales were
$333.8 million for the quarter, an 11% increase versus the prior year. Sales volume increased 8% mostly due to higher demand for products sold into the consumer product end markets, driven by increased demand for cleaning, disinfection and personal wash products as a result of COVID-19. Higher sales volume to our Tier 2/3 customers and higher demand into the global agricultural market also contributed to this increase. This growth was partially offset by lower demand in the oilfield market. Selling prices were up 7% and the translation impact of a strongerU.S. dollar negatively impacted net sales by 4%. The higher selling prices primarily reflect improved product and customer mix. Surfactant operating income increased$21.5 million , or 109%, versus the prior year primarily due to the strong sales volume growth, a$3.9 million operating improvement inMexico , and a partial$2.2 million insurance recovery related to the first quarter 2020 Millsdale, IL plant power outage. - Polymer net sales were
$116.7 million for the quarter, a 14% decrease versus the prior year. Sales volume decreased 5% primarily due to lower North American demand for rigid polyols used in rigid foam insulation and lower phthalic anhydride demand. The lower rigid polyols demand reflects COVID-19 construction project delays and cancellations. On a global basis, the demand for rigid polyols is gradually improving. Selling prices declined 9% versus the prior year third quarter. Polymer operating income decreased$0.9 million , or 4% versus the prior year quarter primarily due to the lower sales volume and margins inNorth America . The lower North American margins reflect incremental raw material costs as a result of the previously disclosedIllinois River lock closures. Operating income in the current year quarter benefited from a partial$2.8 million insurance recovery related to the first quarter 2020 Millsdale, IL plant power outage. - Specialty Product net sales were
$14.0 million for the quarter, a 17% decrease versus the prior year. Sales volume was flat between quarters. Operating income decreased$0.7 million versus the prior year quarter primarily due to lower margins within our medium chain triglycerides (MCT) product line and customer order patterns within our food and flavor business.
Corporate Expenses
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2020 |
2019 |
% Change |
2020 |
2019 |
% Change |
||||||||||||||||||
Total Corporate Expenses |
$ |
22,736 |
$ |
17,238 |
32 |
% |
$ |
53,021 |
$ |
59,666 |
(11) |
% |
||||||||||||
Less: |
||||||||||||||||||||||||
Deferred Compensation |
$ |
5,613 |
$ |
1,610 |
249 |
% |
$ |
4,754 |
$ |
11,478 |
(59) |
% |
||||||||||||
Business Restructuring |
$ |
126 |
$ |
459 |
(73) |
% |
$ |
708 |
$ |
1,642 |
(57) |
% |
||||||||||||
Adjusted Corporate Expenses |
$ |
16,997 |
$ |
15,169 |
12 |
% |
$ |
47,559 |
$ |
46,546 |
2 |
% |
* See Table III for a discussion of deferred compensation plan accounting. |
- Corporate expenses, excluding deferred compensation and business restructuring expenses, increased
$1.8 million , or 12% for the quarter. The quarterly increase was primarily attributable to higher incentive-based compensation expense and higher consulting expenses. The higher consulting expenses were partially related to acquisition activities. Corporate expenses were up 2% on a nine-month basis.
Income Taxes and Net Interest
The Company's effective tax rate was 23.7% for the first nine months of 2020 versus 17.3% for the first nine months of 2019. This year-over-year increase was primarily attributable to: (i) the non-recurrence of favorable research and development tax credits recognized in the third quarter of 2019, and; (ii) a less favorable geographical mix of income in the first nine months of 2020 versus the same period in 2019.
Shareholder Return
The Company paid
Selected Balance Sheet Information
The Company's net debt level decreased
($ in millions) |
|
|
|
|
||||||||||||
Net Debt |
||||||||||||||||
Total Debt |
$ |
207.9 |
$ |
207.9 |
$ |
222.1 |
$ |
222.1 |
||||||||
Cash |
310.4 |
272.9 |
254.3 |
315.4 |
||||||||||||
Net Debt |
$ |
(102.5) |
$ |
(65.0) |
$ |
(32.2) |
$ |
(93.3) |
||||||||
Equity |
938.2 |
897.4 |
866.8 |
891.8 |
||||||||||||
Net Debt + Equity |
$ |
835.7 |
$ |
832.4 |
$ |
834.6 |
$ |
798.5 |
||||||||
Net Debt / (Net Debt + Equity) |
-12 |
% |
-8 |
% |
-4 |
% |
-12 |
% |
The major working capital components were:
($ in millions) |
|
|
|
|
||||||||||||
Net Receivables |
$ |
295.6 |
$ |
286.7 |
$ |
290.6 |
$ |
276.8 |
||||||||
Inventories |
202.3 |
208.2 |
198.2 |
203.6 |
||||||||||||
Accounts Payable |
(207.6) |
(187.4) |
(187.9) |
(194.3) |
||||||||||||
$ |
290.3 |
$ |
307.5 |
$ |
300.9 |
$ |
286.1 |
Capital spending was
Outlook
"Adjusted net income for the first nine months of 2020 was a record
Conference Call
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Headquartered in
The Company's common stock is traded on the
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com
Contact:
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about
There are a number of risks, uncertainties and other important factors, many of which are beyond
These forward-looking statements are made only as of the date hereof, and
Table I |
||||||||||||||||
For the Three and Nine Months Ended (Unaudited – 000's Omitted) |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
|
$ |
464,480 |
$ |
451,582 |
$ |
1,375,016 |
$ |
1,413,755 |
||||||||
Cost of Sales |
367,423 |
374,180 |
1,100,195 |
1,158,785 |
||||||||||||
Gross Profit |
97,057 |
77,402 |
274,821 |
254,970 |
||||||||||||
Operating Expenses: |
||||||||||||||||
Selling |
13,266 |
14,186 |
39,719 |
42,295 |
||||||||||||
Administrative |
21,354 |
19,708 |
60,957 |
60,558 |
||||||||||||
Research, Development and Technical Services |
14,303 |
13,473 |
41,661 |
40,228 |
||||||||||||
Deferred Compensation Expense |
5,613 |
1,610 |
4,754 |
11,478 |
||||||||||||
54,536 |
48,977 |
147,091 |
154,559 |
|||||||||||||
Business Restructuring |
126 |
459 |
708 |
1,642 |
||||||||||||
Operating Income |
42,395 |
27,966 |
127,022 |
98,769 |
||||||||||||
Other Income (Expense): |
||||||||||||||||
Interest, Net |
(1,626) |
(1,402) |
(4,115) |
(5,021) |
||||||||||||
Other, Net |
2,629 |
885 |
3,804 |
4,265 |
||||||||||||
1,003 |
(517) |
(311) |
(756) |
|||||||||||||
Income Before Income Taxes |
43,398 |
27,449 |
126,711 |
98,013 |
||||||||||||
Provision for Income Taxes |
10,056 |
1,569 |
29,987 |
16,945 |
||||||||||||
Net Income |
33,342 |
25,880 |
96,724 |
81,068 |
||||||||||||
Net Income (Income) Loss Attributable to Noncontrolling Interests |
(174) |
9 |
(304) |
23 |
||||||||||||
Net Income Attributable to |
$ |
33,168 |
$ |
25,889 |
$ |
96,420 |
$ |
81,091 |
||||||||
Net Income Per Common Share Attributable to |
||||||||||||||||
Basic |
$ |
1.45 |
$ |
1.12 |
$ |
4.20 |
$ |
3.52 |
||||||||
Diluted |
$ |
1.43 |
$ |
1.11 |
$ |
4.15 |
$ |
3.48 |
||||||||
Shares Used to Compute Net Income Per Common Share Attributable to |
||||||||||||||||
Basic |
22,907 |
23,025 |
22,951 |
23,070 |
||||||||||||
Diluted |
23,237 |
23,300 |
23,236 |
23,320 |
||||||||||||
Table II |
||||||||||||||||||||||||||||||||
Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share * |
||||||||||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2020 |
EPS |
2019 |
EPS |
2020 |
EPS |
2019 |
EPS |
||||||||||||||||||||||||
Net Income Reported |
$ |
33,168 |
$ |
1.43 |
$ |
25,889 |
$ |
1.11 |
$ |
96,420 |
$ |
4.15 |
$ |
81,091 |
$ |
3.48 |
||||||||||||||||
Deferred Compensation (Income) Expense |
$ |
2,612 |
$ |
0.11 |
$ |
1,392 |
$ |
0.06 |
$ |
1,692 |
$ |
0.07 |
$ |
6,482 |
$ |
0.28 |
||||||||||||||||
Business Restructuring Expense |
$ |
95 |
$ |
0.00 |
$ |
334 |
$ |
0.02 |
$ |
526 |
$ |
0.02 |
$ |
1,199 |
$ |
0.05 |
||||||||||||||||
Cash-Settled SARs (Income) Expense |
$ |
546 |
$ |
0.02 |
$ |
314 |
$ |
0.01 |
$ |
256 |
$ |
0.01 |
$ |
1,765 |
$ |
0.08 |
||||||||||||||||
Environmental Remediation Expense |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
2,210 |
$ |
0.09 |
||||||||||||||||||||
Voluntary Debt Prepayment Expense |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
948 |
$ |
0.04 |
||||||||||||||||||||
Adjusted Net Income |
$ |
36,421 |
$ |
1.56 |
$ |
27,929 |
$ |
1.20 |
$ |
98,894 |
$ |
4.25 |
$ |
93,695 |
$ |
4.02 |
* All amounts in this table are presented after-tax |
The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and provide better clarity on the impact of non-operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators. These measures should be considered in addition to, neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP. |
||||||||||||||||||||||||||||||||
Reconciliation of Pre-Tax to After-Tax Adjustments |
||||||||||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2020 |
EPS |
2019 |
EPS |
2020 |
EPS |
2019 |
EPS |
||||||||||||||||||||||||
Pre-Tax Adjustments |
||||||||||||||||||||||||||||||||
Deferred Compensation (Income) Expense |
$ |
3,437 |
$ |
1,831 |
$ |
2,227 |
$ |
8,529 |
||||||||||||||||||||||||
Business Restructuring Expense |
$ |
126 |
$ |
459 |
$ |
708 |
$ |
1,642 |
||||||||||||||||||||||||
Cash-Settled SARs (Income) Expense |
$ |
718 |
$ |
413 |
$ |
337 |
$ |
2,322 |
||||||||||||||||||||||||
Environmental Remediation Expense |
$ |
- |
$ |
- |
$ |
- |
$ |
2,908 |
||||||||||||||||||||||||
Voluntary Debt Prepayment Expense |
$ |
- |
$ |
- |
$ |
- |
$ |
1,247 |
||||||||||||||||||||||||
Total Pre-Tax Adjustments |
$ |
4,281 |
$ |
2,703 |
$ |
3,272 |
$ |
16,648 |
||||||||||||||||||||||||
Cumulative Tax Effect on Adjustments |
$ |
(1,028) |
$ |
(663) |
$ |
(798) |
$ |
(4,044) |
||||||||||||||||||||||||
After-Tax Adjustments |
$ |
3,253 |
$ |
0.13 |
$ |
2,040 |
$ |
0.09 |
$ |
2,474 |
$ |
0.10 |
$ |
12,604 |
$ |
0.54 |
Table III |
||||||||||||||||||||||||||||||
Deferred Compensation Plan |
||||||||||||||||||||||||||||||
The full effect of the deferred compensation plan on quarterly pretax income was |
||||||||||||||||||||||||||||||
2020 |
2019 |
|||||||||||||||||||||||||||||
12/31 |
9/30 |
6/30 |
3/31 |
12/31 |
9/30 |
6/30 |
3/31 |
|||||||||||||||||||||||
|
N/A |
$ |
109.00 |
$ |
97.10 |
$ |
88.46 |
$ |
102.44 |
$ |
97.06 |
$ |
91.91 |
$ |
87.52 |
|||||||||||||||
The deferred compensation income statement impact is summarized below: |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
($ in thousands) |
2020 |
2019 |
2020 |
2019 |
||||||||||||
Deferred Compensation |
||||||||||||||||
Operating Income (Expense) |
$ |
(5,613) |
$ |
(1,610) |
$ |
(4,754) |
$ |
(11,478) |
||||||||
Other, net – Mutual Fund Gain (Loss) |
2,176 |
(221) |
2,527 |
2,949 |
||||||||||||
Total Pre-Tax |
$ |
(3,437) |
$ |
(1,831) |
$ |
(2,227) |
$ |
(8,529) |
||||||||
Total After-Tax |
$ |
(2,612) |
$ |
(1,392) |
$ |
(1,692) |
$ |
(6,482) |
Table IV |
||||||||||||||||||||||||||||||||
Effects of Foreign Currency Translation |
||||||||||||||||||||||||||||||||
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into |
||||||||||||||||||||||||||||||||
($ in millions) |
Three Months Ended |
Increase |
Decrease Due to Foreign Currency Translation |
Nine Months Ended |
Increase (Decrease) |
Decrease Due to Foreign Currency Translation |
||||||||||||||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||||||||||||||||||
|
$ |
464.5 |
$ |
451.6 |
$ |
12.9 |
$ |
(9.7) |
$ |
1,375.0 |
$ |
1,413.8 |
$ |
(38.8) |
$ |
(38.2) |
||||||||||||||||
Gross Profit |
97.1 |
77.4 |
19.7 |
(2.7) |
274.8 |
255.0 |
19.8 |
(8.4) |
||||||||||||||||||||||||
Operating Income |
42.4 |
28.0 |
14.4 |
(2.2) |
127.0 |
98.8 |
28.2 |
(6.3) |
||||||||||||||||||||||||
Pretax Income |
43.4 |
27.4 |
16.0 |
(2.1) |
126.7 |
98.0 |
28.7 |
(6.2) |
Table V |
||||||||
Consolidated Balance Sheets |
||||||||
|
|
|||||||
ASSETS |
||||||||
Current Assets |
$ |
833,036 |
$ |
818,789 |
||||
Property, Plant & Equipment, Net |
651,686 |
639,317 |
||||||
Other Assets |
132,929 |
121,261 |
||||||
Total Assets |
$ |
1,617,651 |
$ |
1,579,367 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||
Current Liabilities |
$ |
361,166 |
$ |
339,114 |
||||
Deferred Income Taxes |
23,994 |
23,391 |
||||||
Long-term Debt |
170,063 |
198,532 |
||||||
Other Non-current Liabilities |
123,192 |
125,834 |
||||||
Total Stepan Company Stockholders' Equity |
938,193 |
891,783 |
||||||
Noncontrolling Interest |
1,043 |
713 |
||||||
Total Liabilities and Stockholders' Equity |
$ |
1,617,651 |
$ |
1,579,367 |
View original content:http://www.prnewswire.com/news-releases/stepan-reports-record-third-quarter-results-and-nine-month-earnings-301156577.html
SOURCE